REDUCED CALORIES, PROLIFERATION, IMMUNITY, CANCER, AGING
减少热量、增殖、免疫力、癌症、衰老
基本信息
- 批准号:2899726
- 负责人:
- 金额:$ 16.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-01-01 至 2001-03-31
- 项目状态:已结题
- 来源:
- 关键词:aging autoradiography breast neoplasms caloric dietary content cell growth regulation growth factor hepatectomy histology intestines laboratory mouse laboratory rat liver liver regeneration mammary gland neoplasm /cancer immunology northern blottings nutrition of aging nutrition related neoplasm /cancer nutrition related tag skin
项目摘要
This project has as its primary focus to achieve basic understanding of
the influence of undernutrition without malnutrition -- chronic energy
intake restriction (CEIR) which greatly increases life span and health
span of rats and of mice of long-lived, and of short-lived autoimmune-
prone and cancer-prone strains. We are attempting especially to analyze
the mechanisms which underlie prevention by CEIR of retrovirus-induced
mammary adenocarcinoma, certain autoimmunities, vascular diseases,
malignancies and immunodeficiency disorders that develop with aging in
mice of certain genetically short-lived strains, as well as the
immunodeficiency associated with aging in mice of some long-lived strains.
Particularly, we have discovered that CEIR down-regulates (tunes down)
many forms of what we call vegetative and reproduction associated cellular
proliferation -- while at the same time CEIR up-regulates cellular
proliferation that is associated with liver regenerative repair following
partial hepatectomy. Our experiments will attempt to analyze at the
molecular level in one representative long-lived and in one representative
short-lived strain and in one strain of mice in which females develop
mammary adenocarcinoma in high frequency, how CEIR influences expression
and production of growth factors that in turn influence and control cell
proliferation in mammary gland epithelium, skin and esophageal and
intestinal epithelium. We will also analyze how CEIR influences the
expression and production of complete hepatic growth factors and a new
augmentor of liver regeneration and how these actions influence hepatic
cellular regeneration after partial hepatectomy. It is our view that the
influence of CEIR on these crucial vegetative and adaptive proliferations
play crucial roles in the action of CEIR to prolong life, prolong the span
of health and prevent development of diseases which occur with aging such
as cancers and autoimmunities.
该项目的主要重点是实现对
没有营养不良的营养不良的影响 - 慢性能量
摄入限制(CEIR)大大增加了寿命和健康
长寿命和短暂的自身免疫的大鼠和小鼠的跨度
容易发生且容易发生癌症。 我们正在尝试特别分析
逆转录病毒诱导的CEIR预防的机制
乳腺腺癌,某些自身免疫,血管疾病,
随着衰老而发展的恶性肿瘤和免疫缺陷障碍
某些遗传菌株的小鼠以及
与某些长寿命菌株的小鼠衰老相关的免疫缺陷。
特别是,我们发现CEIR会下调(调节)
我们称之为营养和繁殖相关的细胞的多种形式
增殖 - 同时CEIR上调了细胞
与肝脏再生维修相关的增殖
部分肝切除术。 我们的实验将尝试在
一个代表性的长寿和一个代表性的分子水平
短寿命的菌株和女性发展的一只小鼠
高频的乳腺腺癌,CEIR如何影响表达
以及生长因子的产生又影响和控制细胞
乳腺上皮,皮肤和食管的增殖
肠上皮。 我们还将分析CEIR如何影响
表达和生产完整的肝增长因子和新的
肝脏再生的增强子以及这些动作如何影响肝
部分肝切除术后的细胞再生。 我们认为
CEIR对这些至关重要的营养和适应性增殖的影响
在CEIR延长寿命的行动中扮演至关重要的角色,延长跨度
健康并防止随着这种衰老而发生的疾病
作为癌症和自身免疫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A GOOD其他文献
THE δTCS1 DETERMINANT IS EXPRESSED ON BOTH DISULFIDE- AND NON–DISULFIDE-LINKED γδ T-CELL ANTIGEN RECEPTORS
- DOI:
10.1182/blood.v77.10.2301.2301 - 发表时间:
1991-05-15 - 期刊:
- 影响因子:
- 作者:
CHRIS D. PLATSOUCAS;MASANOBU NANNO;HIDETOSHI SEKI;GEORGE MATHIOUDAKIS;NOORBIBIK. DAY;ROBERT A GOOD - 通讯作者:
ROBERT A GOOD
ROBERT A GOOD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A GOOD', 18)}}的其他基金
REDUCED CALORIES, PROLIFERATION, IMMUNITY, CANCER, AGING
减少热量、增殖、免疫力、癌症、衰老
- 批准号:
2049186 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
CELLULAR ENGINEERING TO TREAT/PREVENT DISEASES OF AGING
治疗/预防衰老疾病的细胞工程
- 批准号:
2390013 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
REDUCED CALORIES, PROLIFERATION, IMMUNITY, CANCER, AGING
减少热量、增殖、免疫力、癌症、衰老
- 批准号:
2001200 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
CELLULAR ENGINEERING TO TREAT/PREVENT DISEASES OF AGING
治疗/预防衰老疾病的细胞工程
- 批准号:
6027433 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
REDUCED CALORIES, PROLIFERATION, IMMUNITY, CANCER, AGING
减少热量、增殖、免疫力、癌症、衰老
- 批准号:
3116293 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
CELLULAR ENGINEERING TO TREAT/PREVENT DISEASES OF AGING
治疗/预防衰老疾病的细胞工程
- 批准号:
2049179 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
CELLULAR ENGINEERING TO TREAT/PREVENT DISEASES OF AGING
治疗/预防衰老疾病的细胞工程
- 批准号:
2049177 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
CELLULAR ENGINEERING TO TREAT/PREVENT DISEASES OF AGING
治疗/预防衰老疾病的细胞工程
- 批准号:
2049178 - 财政年份:1985
- 资助金额:
$ 16.01万 - 项目类别:
相似国自然基金
适用于放射自显影的GAGG/SiPM探测器的空间分辨率物理极限研究
- 批准号:62001466
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
紫茎泽兰根际微生物群落结构、多样性和功能研究
- 批准号:31360026
- 批准年份:2013
- 资助金额:50.0 万元
- 项目类别:地区科学基金项目
用32P的放射自显影技术对经络循行路路线物质基础研究
- 批准号:39570856
- 批准年份:1995
- 资助金额:6.0 万元
- 项目类别:面上项目
大鼠全脑对针刺内关穴位的特异性反应
- 批准号:39570855
- 批准年份:1995
- 资助金额:6.0 万元
- 项目类别:面上项目
细菌周膜与内质网关系的电镜细胞化学和放射自显影研究
- 批准号:39070436
- 批准年份:1990
- 资助金额:3.5 万元
- 项目类别:面上项目
相似海外基金
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 16.01万 - 项目类别:
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization
乳腺癌 PARP PET 成像 AIP 支持 FDA 批准
- 批准号:
10577744 - 财政年份:2021
- 资助金额:
$ 16.01万 - 项目类别:
A novel PARP inhibitor PET tracer for breast cancer
一种新型 PARP 抑制剂 PET 示踪剂用于乳腺癌
- 批准号:
10623144 - 财政年份:2021
- 资助金额:
$ 16.01万 - 项目类别:
A novel PARP inhibitor PET tracer for breast cancer
一种新型 PARP 抑制剂 PET 示踪剂用于乳腺癌
- 批准号:
10374063 - 财政年份:2021
- 资助金额:
$ 16.01万 - 项目类别:
Breast Cancer PARP PET Imaging AIP to Support FDA Approval & Commercialization
乳腺癌 PARP PET 成像 AIP 支持 FDA 批准
- 批准号:
10183011 - 财政年份:2021
- 资助金额:
$ 16.01万 - 项目类别: